Has Eric Yang, MD received payments from drug or device companies?

Yes. Drug and device makers reported $31,775 in general payments to Eric Yang, MD across 165 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Eric Yang, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Eric Yang, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Eric Yang, MD

Surgery · la Grange Highlands, ILNPI 1669420113

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (44.1%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 86.4% of it on its own, with 27 other manufacturers making up the rest. 2025 is the largest year on record at $13,176, 6.8 times the $1,946 reported in 2019. Among surgery clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$31,775in general payments, 2019–2025

Across 165 payments — averaging $192.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Smith+Nephew$27K
Organogenesis Inc.$1K
Kerecis Limited$665
Mimedx Group, Inc.$420
KCI USA, Inc.$318
Urgo Medical North America, LLC$300
plus $1K from 22 others

What the payments were for

Consulting fees$6,32520%
Speaking & faculty fees$14,02544%
Travel & lodging$2,1057%
Food & beverage$9,25729%
Education$620%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Smith+Nephew	92	$27,460
Organogenesis Inc.	20	$1,280
Kerecis Limited	4	$665
Mimedx Group, Inc.	3	$420
KCI USA, Inc.	4	$318
Urgo Medical North America, LLC	3	$300
Intuitive Surgical	4	$292
Solventum Corporation	4	$186
Tactile Systems Technology Inc	2	$137
Aroa Biosurgery Incorporated	2	$114
Shire North American Group Inc	5	$72
ETS Wound Care LLC	2	$56
Davol Inc.	1	$50
Bsn Medical Inc	1	$46
Angiodynamics, Inc.	1	$42
Myriad Genetic Laboratories, Inc.	2	$40
Baxter Healthcare	1	$38
Takeda Pharmaceuticals U.S.A., Inc.	2	$37
Polynovo North America LLC	1	$34
Kowa Pharmaceuticals America, Inc.	2	$29
Lifenet Health	1	$27
Merck	2	$26
Stryker	1	$21
Melinta Therapeutics, LLC	1	$21
Pfizer	1	$18
Paratek Pharmaceuticals, Inc.	1	$17
Medela LLC	1	$16
AbbVie	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$31,775 in reported general payments places this provider in the 90th percentile of 1,180 surgery providers in Illinois.

See all surgery providers in Illinois →

Medicare billing

Part B allowed, 2024

$109,065

Medicare patients

136

Services billed

1,298

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Pentoxifylline	99	$2,149

Paid to pharmacies, not to this prescriber.

Other surgery in la Grange Highlands

Jaishankar RamanBurr Ridge$1.6M
Reza GamagamiNew Lenox$1.2M
Francesco BiancoChicago$1M
Mark KeldahlChicago$765K
Barry RosenBarrington$443K
Douglas JonesChampaign$425K
Rami LutfiChicago$411K
Paul VanaDowners Grove$368K
Erik BorncampNew Lenox$364K
Michael UjikiEvanston$276K

See the full list for Illinois →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →